And Canopy Growth, near-term stumbles aside, still is in prime position to benefit. But increasingly the huge gains in cannabis stocks last year — driven precisely by Constellation’s $4 billion …
More Two Key Reasons Not to Buy the Dip in Canopy Growth Stock Videos